Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets (Unaudited)

v3.23.1
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
Mar. 31, 2023
Dec. 31, 2022
Current Assets    
Cash and Cash Equivalents $ 188,548 $ 749,090
Marketable Securities 15,359,954 4,086,902
Prepaid Expenses 738,138 565,787
Total Current Assets 16,286,640 5,401,779
Non-Current Assets    
Operating Lease Right-of-Use Assets 123,815 139,662
Goodwill 10,498,539 10,498,539
Investment in Oravax, Inc. 1,500,000 1,500,000
Total Non-Current Assets 12,122,354 12,138,201
Total Assets 28,408,994 17,539,980
Current Liabilities    
Trade and Other Payables 1,369,200 2,673,221
Due to MyMD Florida Shareholders $ 29,982 $ 29,982
Other Liability, Current, Related and Nonrelated Party Status [Extensible Enumeration] us-gaap:RelatedPartyMember us-gaap:RelatedPartyMember
Operating Lease Liability $ 68,004 $ 65,780
Dividends Payable 158,333
Total Current Liabilities 1,625,519 2,768,983
Non-Current Liabilities    
Operating Lease Liability, net of current portion 58,027 75,941
Derivative Liabilities 3,270,500
Warrant Liabilities 9,448,000
Total Non-Current Liabilities 12,776,527 75,941
Total Liabilities 14,402,046 2,844,924
Commitments and Contingencies
STOCKHOLDERS’ EQUITY    
Common stock, no par value, 500,000,000 shares authorized 39,470,009 issued and outstanding as of March 31, 2023 and December 31, 2022 108,378,504 108,309,436
Accumulated Deficit (95,428,969) (93,758,904)
Total Stockholders’ Equity 13,094,059 14,695,056
Total Liabilities and Stockholders’ Equity 28,408,994 17,539,980
Series F Convertible Preferred Stock [Member]    
Non-Current Liabilities    
Series F Convertible Preferred Stock, 15,000 shares designated, no par value and a stated value of $1,000 per share, 15,000 and 0 shares issued and outstanding as of March 31, 2023 and December 31, 2022. Liquidation preference of $15,000,000 plus dividends at 10% per annum of $158,333 as of March 31, 2023. 912,889
Series D Convertible Preferred Stock [Member]    
STOCKHOLDERS’ EQUITY    
Preferred stock value $ 144,524 $ 144,524